drugset / Trial / NCT00690534

Insulin and Sarcopenia in the Elderly

NCT00690534

RandomizedParallel-groupOpen-labelBasic science

Summary

Muscle loss with aging is a significant contributor to disability in older people. Our general hypothesis is that loss of muscle with aging, known as sarcopenia, may be due to inability of muscle to grow in response to insulin. Our goal is to determine the mechanisms underlying this age-related insulin resistance of muscle proteins, which will allow us to define in the future specific interventions to target this defect and provide the scientific basis for the prevention and treatment of sarcopenia.

Timeline

Start
2005-09
Primary completion
2012-08
Completion
2012-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 0.2 iu/kg Other
Subject L-NMMA Unknown Other
Subject Sodium Nitroprusside Unknown Other

Indications